Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 449 entries
Sorted by: Best Match Show Resources per page
[Hospital life in variety: the United States, Germany, and Japan].

[Kango] Japanese journal of nursing

Kadowaki S.
PMID: 5204859
Kango. 1970 Oct;22(10):53-9.

No abstract available.

Cite
Kadowaki S. [Hospital life in variety: the United States, Germany, and Japan]. Kango. 1970;22(10):53-9
Kadowaki, S. (1970). [Hospital life in variety: the United States, Germany, and Japan]. [Kango] Japanese journal of nursing, 22(10), 53-9.
Kadowaki, S. "[Hospital life in variety: the United States, Germany, and Japan]." [Kango] Japanese journal of nursing vol. 22,10 (1970): 53-9.
Kadowaki S. [Hospital life in variety: the United States, Germany, and Japan]. Kango. 1970 Oct;22(10):53-9. Japanese. PMID: 5204859.
Copy Download .nbib Format: NLM
Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals.

Physical review letters

Tsujimoto M, Yamamoto T, Delfanazari K, Nakayama R, Kitamura T, Sawamura M, Kashiwagi T, Minami H, Tachiki M, Kadowaki K, Klemm RA.
PMID: 22463446
Phys Rev Lett. 2012 Mar 09;108(10):107006. doi: 10.1103/PhysRevLett.108.107006. Epub 2012 Mar 09.

Continuous, coherent subterahertz radiation arises when a dc voltage is applied across a stack of the many intrinsic Josephson junctions in a Bi2Sr2CaCu2O(8+δ) single crystal. The active junctions produce an equal number of I-V characteristic branches. Each branch radiates...

Cite
Tsujimoto M, Yamamoto T, Delfanazari K, et al. Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Phys Rev Lett. 2012;108(10):107006doi: 10.1103/PhysRevLett.108.107006.
Tsujimoto, M., Yamamoto, T., Delfanazari, K., Nakayama, R., Kitamura, T., Sawamura, M., Kashiwagi, T., Minami, H., Tachiki, M., Kadowaki, K., & Klemm, R. A. (2012). Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Physical review letters, 108(10), 107006. https://doi.org/10.1103/PhysRevLett.108.107006
Tsujimoto, Manabu, et al. "Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals." Physical review letters vol. 108,10 (2012): 107006. doi: https://doi.org/10.1103/PhysRevLett.108.107006
Tsujimoto M, Yamamoto T, Delfanazari K, Nakayama R, Kitamura T, Sawamura M, Kashiwagi T, Minami H, Tachiki M, Kadowaki K, Klemm RA. Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Phys Rev Lett. 2012 Mar 09;108(10):107006. doi: 10.1103/PhysRevLett.108.107006. Epub 2012 Mar 09. PMID: 22463446.
Copy Download .nbib Format: NLM
Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report.

Journal of anesthesia

Horiguchi T, Enzan K, Matsumoto J, Kadosaki M, Suzuki M.
PMID: 28921368
J Anesth. 1994 Dec;8(4):503-505. doi: 10.1007/BF02514639.

No abstract available.

Cite
Horiguchi T, Enzan K, Matsumoto J, et al. Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report. J Anesth. 1994;8(4):503-505doi: 10.1007/BF02514639.
Horiguchi, T., Enzan, K., Matsumoto, J., Kadosaki, M., & Suzuki, M. (1994). Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report. Journal of anesthesia, 8(4), 503-505. https://doi.org/10.1007/BF02514639
Horiguchi, Takashi, et al. "Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report." Journal of anesthesia vol. 8,4 (1994): 503-505. doi: https://doi.org/10.1007/BF02514639
Horiguchi T, Enzan K, Matsumoto J, Kadosaki M, Suzuki M. Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report. J Anesth. 1994 Dec;8(4):503-505. doi: 10.1007/BF02514639. PMID: 28921368.
Copy Download .nbib Format: NLM
A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.

Clinical case reports

Umeda M, Kondo T, Nishikori M, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A.
PMID: 26783429
Clin Case Rep. 2015 Nov 09;4(1):23-5. doi: 10.1002/ccr3.436. eCollection 2016 Jan.

Currently, there is no standard treatment for neurolymphomatosis because of the scarcity of clinical studies. Here, we report the successful treatment of neurolymphomatosis caused by follicular lymphoma with bendamustine, which could be an effective treatment option for this condition.

Cite
Umeda M, Kondo T, Nishikori M, et al. A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clin Case Rep. 2015;4(1):23-5doi: 10.1002/ccr3.436.
Umeda, M., Kondo, T., Nishikori, M., Kitano, T., Hishizawa, M., Kadowaki, N., & Takaori-Kondo, A. (2016). A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clinical case reports, 4(1), 23-5. https://doi.org/10.1002/ccr3.436
Umeda, Masayuki, et al. "A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine." Clinical case reports vol. 4,1 (2016): 23-5. doi: https://doi.org/10.1002/ccr3.436
Umeda M, Kondo T, Nishikori M, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A. A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clin Case Rep. 2015 Nov 09;4(1):23-5. doi: 10.1002/ccr3.436. eCollection 2016 Jan. PMID: 26783429; PMCID: PMC4706405.
Copy Download .nbib Format: NLM
Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease.

Diabetes research and clinical practice

Ohtomo K, Shigeeda T, Hirose A, Ohno T, Kinoshita O, Fujita H, Ando J, Nagai R, Takamoto S, Kadowaki T, Kato S.
PMID: 27371781
Diabetes Res Clin Pract. 2016 Aug;118:154-5. doi: 10.1016/j.diabres.2016.06.016. Epub 2016 Jun 17.

No abstract available.

Cite
Ohtomo K, Shigeeda T, Hirose A, et al. Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes Res Clin Pract. 2016;118:154-5doi: 10.1016/j.diabres.2016.06.016.
Ohtomo, K., Shigeeda, T., Hirose, A., Ohno, T., Kinoshita, O., Fujita, H., Ando, J., Nagai, R., Takamoto, S., Kadowaki, T., & Kato, S. (2016). Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes research and clinical practice, 118154-5. https://doi.org/10.1016/j.diabres.2016.06.016
Ohtomo, Kazuyoshi, et al. "Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease." Diabetes research and clinical practice vol. 118 (2016): 154-5. doi: https://doi.org/10.1016/j.diabres.2016.06.016
Ohtomo K, Shigeeda T, Hirose A, Ohno T, Kinoshita O, Fujita H, Ando J, Nagai R, Takamoto S, Kadowaki T, Kato S. Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes Res Clin Pract. 2016 Aug;118:154-5. doi: 10.1016/j.diabres.2016.06.016. Epub 2016 Jun 17. PMID: 27371781.
Copy Download .nbib Format: NLM
Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis.

Diabetes care

Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T.
PMID: 29449311
Diabetes Care. 2018 Apr;41(4):e52-e55. doi: 10.2337/dc17-2095. Epub 2018 Feb 15.

No abstract available.

Cite
Yamada T, Shojima N, Noma H, et al. Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2018;41(4):e52-e55doi: 10.2337/dc17-2095.
Yamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2018). Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes care, 41(4), e52-e55. https://doi.org/10.2337/dc17-2095
Yamada, Tomohide, et al. "Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis." Diabetes care vol. 41,4 (2018): e52-e55. doi: https://doi.org/10.2337/dc17-2095
Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2018 Apr;41(4):e52-e55. doi: 10.2337/dc17-2095. Epub 2018 Feb 15. PMID: 29449311.
Copy Download .nbib Format: NLM
Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population.

Journal of diabetes investigation

Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A, Kadowaki T, Kawamori R, Maeda S.
PMID: 24843648
J Diabetes Investig. 2013 Mar 18;4(2):168-73. doi: 10.1111/jdi.12017. Epub 2012 Nov 28.

AIMS/INTRODUCTION: Genetic risk variants for type 2 diabetes; rs391300-G in SRR and rs17584499-T in PTPRD, have been identified by a genome-wide association study using Han Chinese individuals living in Taiwan. In an attempt to know the effects of these...

Cite
Imamura M, Iwata M, Maegawa H, et al. Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population. J Diabetes Investig. 2012;4(2):168-73doi: 10.1111/jdi.12017.
Imamura, M., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kadowaki, T., Kawamori, R., & Maeda, S. (2013). Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population. Journal of diabetes investigation, 4(2), 168-73. https://doi.org/10.1111/jdi.12017
Imamura, Minako, et al. "Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population." Journal of diabetes investigation vol. 4,2 (2013): 168-73. doi: https://doi.org/10.1111/jdi.12017
Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A, Kadowaki T, Kawamori R, Maeda S. Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population. J Diabetes Investig. 2013 Mar 18;4(2):168-73. doi: 10.1111/jdi.12017. Epub 2012 Nov 28. PMID: 24843648; PMCID: PMC4019271.
Copy Download .nbib Format: NLM
Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus.

Journal of diabetes investigation

Kadowaki T, Kondo K.
PMID: 24843712
J Diabetes Investig. 2013 Nov 27;4(6):576-84. doi: 10.1111/jdi.12092. Epub 2013 May 27.

AIM: To confirm the efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus inadequately controlled with pioglitazone monotherapy.MATERIALS AND METHODS: In an initial 12-week, double-blind, placebo controlled, parallel-group study, patients (n...

Cite
Kadowaki T, Kondo K. Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig. 2013;4(6):576-84doi: 10.1111/jdi.12092.
Kadowaki, T., & Kondo, K. (2013). Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation, 4(6), 576-84. https://doi.org/10.1111/jdi.12092
Kadowaki, Takashi, and Kondo, Kazuoki. "Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus." Journal of diabetes investigation vol. 4,6 (2013): 576-84. doi: https://doi.org/10.1111/jdi.12092
Kadowaki T, Kondo K. Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig. 2013 Nov 27;4(6):576-84. doi: 10.1111/jdi.12092. Epub 2013 May 27. PMID: 24843712; PMCID: PMC4020253.
Copy Download .nbib Format: NLM
Distribution of mitochondrial plasmid-like DNA in cultivated rice (Oryza sativa L.) and its relationship with varietal groups.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Kadowaki K, Yazaki K, Osumi T, Harada K, Katsuta M, Nakagahra M.
PMID: 24232388
Theor Appl Genet. 1988 Dec;76(6):809-14. doi: 10.1007/BF00273665.

Mitochondrial (mt) plasmid-like DNA was found in most of more than 100 rice cultivars (Oryza sativa L.) by the use of 0.7% agarose gel electrophoresis (AGE). The DNA varied in molecular weight and number. By electron microscopy, small circular...

Cite
Kadowaki K, Yazaki K, Osumi T, et al. Distribution of mitochondrial plasmid-like DNA in cultivated rice (Oryza sativa L.) and its relationship with varietal groups. Theor Appl Genet. 1988;76(6):809-14doi: 10.1007/BF00273665.
Kadowaki, K., Yazaki, K., Osumi, T., Harada, K., Katsuta, M., & Nakagahra, M. (1988). Distribution of mitochondrial plasmid-like DNA in cultivated rice (Oryza sativa L.) and its relationship with varietal groups. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 76(6), 809-14. https://doi.org/10.1007/BF00273665
Kadowaki, K, et al. "Distribution of mitochondrial plasmid-like DNA in cultivated rice (Oryza sativa L.) and its relationship with varietal groups." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 76,6 (1988): 809-14. doi: https://doi.org/10.1007/BF00273665
Kadowaki K, Yazaki K, Osumi T, Harada K, Katsuta M, Nakagahra M. Distribution of mitochondrial plasmid-like DNA in cultivated rice (Oryza sativa L.) and its relationship with varietal groups. Theor Appl Genet. 1988 Dec;76(6):809-14. doi: 10.1007/BF00273665. PMID: 24232388.
Copy Download .nbib Format: NLM
Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Journal of diabetes investigation

, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K.
PMID: 24843435
J Diabetes Investig. 2010 Oct 19;1(5):212-28. doi: 10.1111/j.2040-1124.2010.00074.x.

CONCEPT OF DIABETES MELLITUS: Diabetes mellitus is a group of diseases associated with various metabolic disorders, the main feature of which is chronic hyperglycemia due to insufficient insulin action. Its pathogenesis involves both genetic and environmental factors. The long-term...

Cite
, Seino Y, Nanjo K, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1(5):212-28doi: 10.1111/j.2040-1124.2010.00074.x.
, Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., Hanafusa, T., Haneda, M., & Ueki, K. (2010). Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Journal of diabetes investigation, 1(5), 212-28. https://doi.org/10.1111/j.2040-1124.2010.00074.x
, et al. "Report of the committee on the classification and diagnostic criteria of diabetes mellitus." Journal of diabetes investigation vol. 1,5 (2010): 212-28. doi: https://doi.org/10.1111/j.2040-1124.2010.00074.x
, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010 Oct 19;1(5):212-28. doi: 10.1111/j.2040-1124.2010.00074.x. PMID: 24843435; PMCID: PMC4020724.
Copy Download .nbib Format: NLM
Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study.

Journal of diabetes investigation

Kato M, Takahashi Y, Matsushita Y, Mizoue T, Inoue M, Kadowaki T, Tsugane S, Noda M.
PMID: 24843514
J Diabetes Investig. 2011 Oct 07;2(5):359-65. doi: 10.1111/j.2040-1124.2011.00119.x.

UNLABELLED: Aims/Introduction:  Although several risk factors for type 2 diabetes have been identified, most of them have been identified in studies on Western populations, and they should be evaluated in a Japanese population. In 2010, new diagnostic criteria for...

Cite
Kato M, Takahashi Y, Matsushita Y, et al. Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study. J Diabetes Investig. 2011;2(5):359-65doi: 10.1111/j.2040-1124.2011.00119.x.
Kato, M., Takahashi, Y., Matsushita, Y., Mizoue, T., Inoue, M., Kadowaki, T., Tsugane, S., & Noda, M. (2011). Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study. Journal of diabetes investigation, 2(5), 359-65. https://doi.org/10.1111/j.2040-1124.2011.00119.x
Kato, Masayuki, et al. "Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study." Journal of diabetes investigation vol. 2,5 (2011): 359-65. doi: https://doi.org/10.1111/j.2040-1124.2011.00119.x
Kato M, Takahashi Y, Matsushita Y, Mizoue T, Inoue M, Kadowaki T, Tsugane S, Noda M. Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study. J Diabetes Investig. 2011 Oct 07;2(5):359-65. doi: 10.1111/j.2040-1124.2011.00119.x. PMID: 24843514; PMCID: PMC4019303.
Copy Download .nbib Format: NLM
Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks.

Journal of diabetes investigation

Kadowaki T, Tajima N, Odawara M, Nishii M, Taniguchi T, Ferreira JC.
PMID: 24843649
J Diabetes Investig. 2013 Mar 18;4(2):174-81. doi: 10.1111/jdi.12001. Epub 2012 Oct 22.

AIMS/INTRODUCTION: The efficacy and safety of sitagliptin, a highly selective dipeptidyl peptidase-4 inhibitor, when added to metformin monotherapy was examined in Japanese patients with type 2 diabetes.MATERIALS AND METHODS: In this 52-week, add-on to metformin study, 149 patients were...

Cite
Kadowaki T, Tajima N, Odawara M, et al. Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks. J Diabetes Investig. 2012;4(2):174-81doi: 10.1111/jdi.12001.
Kadowaki, T., Tajima, N., Odawara, M., Nishii, M., Taniguchi, T., & Ferreira, J. C. (2013). Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks. Journal of diabetes investigation, 4(2), 174-81. https://doi.org/10.1111/jdi.12001
Kadowaki, Takashi, et al. "Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks." Journal of diabetes investigation vol. 4,2 (2013): 174-81. doi: https://doi.org/10.1111/jdi.12001
Kadowaki T, Tajima N, Odawara M, Nishii M, Taniguchi T, Ferreira JC. Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks. J Diabetes Investig. 2013 Mar 18;4(2):174-81. doi: 10.1111/jdi.12001. Epub 2012 Oct 22. PMID: 24843649; PMCID: PMC4019272.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 449 entries